Market Cap

Novartis Market Capitalization:

Novartis AG

CHF179.80 Billion

CHF as of Jan. 1, 2023

US$194.45 Billion

business Novartis Company Profile

Novartis Main Stock Listing

show_chart SIX: NOVN

Market capitalization history of Novartis

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Johnson & Johnson $461.85 B
Lilly $347.61 B
Pfizer $287.63 B
AbbVie $285.80 B
Merck $281.30 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Novartis market cap

Date Market Cap YoY Change
Jan. 1, 2023 CHF179.80 B 7.59%
Jan. 1, 2022 CHF167.12 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Novartis Categories

Switzerland languages Healthcare languages Drug Manufacturers—General
Switzerland Healthcare Switzerland Drug Manufacturers—General

Stocks & Indices

Novartis AG has the following listings and related stock indices.


Stock: SIX: NOVN

Stock: NYSE: NVS

Stock: BCBA: NVS

Stock: Bovespa: N1VS34

Stock: FSX: NOTA

Stock: OTC: NVSEF

Stock: SIX: NOVNEE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.